was attended by foremost scientists at both senior and junior level.
The meeting's faculty and participants reflected the high level of diversity of the scientific mast cell and basophil community and were well gender-balanced, with 48% of the oral presentations given by women.
Altogether, 44 oral presentations were given and 57 posters were presented, the latter divided into two well-attended poster sessions.
The meeting covered multiple novel aspects of mast cell/basophil function, as detailed below and in Figures 1 and 2 . A hot current topic is to decipher how mast cells/basophils communicate with other cell types. This was covered by numerous presentations at the meeting, with a particular focus on the interaction between mast cells and dendritic cells, melanoma cells, neurons, CD4 + and CD8 + cells. In several of these presentations, the role of extracellular vesicles in cell-cell communication was discussed. -independent mechanisms. Further, anti-mast cell/basophil therapies using anti-IgE biologicals such as omalizumab and ligelizumab and treatments that target inhibitory receptors were discussed.
Novel strategies for inducing selective mast cell apoptosis were also presented, and mast cell apoptosis as a mechanism of maintaining skin homoeostasis was addressed.
Altogether, the 9th meeting of the (EMBRN) provided a comprehensive update in the field of mast cell/basophil biology. We anticipate that multiple new research initiatives will be taken as a result of the findings presented at the meeting and we also foresee that multiple novel collaborative efforts will be emanating from the meeting, altogether giving rise to joint publications and joint initiatives for grant applications. 
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Mass spectrometry confirmation that clinically important peanut protein allergens are present in household dust
To the editor The route of exposure of peanut in the first year appears to be crucial in determining whether peanut allergy or tolerance develops.
Epicutaneous peanut exposure via an inflamed disrupted skin barrier increases the risk of peanut allergy. 1 Furthermore, there is evidence that perinatal exposure to peanut in dust is associated with the development of peanut sensitization and allergy in children with a disrupted skin barrier. 2 Environmental exposure to peanut in early life is therefore an important factor to quantify and consider in the development of peanut allergy. Previous studies have quantified peanut protein (using a polyclonal whole peanut protein ELISA) and specific peanut allergens (using a monoclonal Ara h 1 ELISA) in household dust and surfaces. 2, 3 Studies linking peanut protein in dust to peanut sensitization used an ELISA employing a polyclonal antibody which has been validated for sensitivity, specificity, and reproducibility with regards analysis of dust samples 4 ; however, given the specificity of the ELISA, 5,6 it does not confirm the presence of peanut allergens (eg, Ara h 2) and isoforms thereof.
We therefore used mass spectrometry (MS) to confirm the presence of peanut proteins present in dust samples previously indicated by ELISA and characterize the repertoire of peanut allergens present.
Dust samples were collected from UK households using a method previously described 4 ; they had high (n = 2, infant's play-area Abbreviations: ELISAs, Enzyme-linked immunosorbent assays; FDR, False Discovery Rate; HPLC, High Performance Liquid Chromatography; MS, Mass spectrometry.
